Ptosis-vocal cord paralysis syndrome

Ptosis-vocal cord paralysis syndrome is an extremely rare genetic disorder characterized by the combination of congenital ptosis (drooping of the upper eyelids) and bilateral vocal cord paralysis. This condition affects the neuromuscular control of both the eyelid muscles (levator palpebrae superioris) and the laryngeal muscles that control vocal cord movement. The vocal cord paralysis can lead to breathing difficulties (stridor), a weak or hoarse cry in infants, and potentially life-threatening airway obstruction. Ptosis may be unilateral or bilateral and can impair vision if severe. The condition has been reported in a very small number of families in the medical literature, making it one of the rarest described syndromes. The underlying pathophysiology is thought to involve a developmental defect in the cranial nerve nuclei or their pathways, particularly affecting the oculomotor nerve (cranial nerve III) controlling the eyelid and the recurrent laryngeal branch of the vagus nerve (cranial nerve X) controlling the vocal cords. Some affected individuals may also exhibit additional features such as facial weakness or other cranial nerve abnormalities. Management is primarily supportive and symptomatic. Vocal cord paralysis may require tracheostomy in severe cases to secure the airway, while ptosis can be addressed surgically through frontalis sling procedures or levator resection to improve vision and cosmesis. No curative treatment is currently available, and long-term follow-up with otolaryngology and ophthalmology specialists is recommended.

Common questions about Ptosis-vocal cord paralysis syndrome